公司资料
GeneDx 股价、新闻与催化剂
- 股票代码:
- WGS
- 交易所:
- NASDAQ
- 行业:
- Biopharma
- 所在地:
- United States
股票表现
87.06 USD (+5.47%)
收盘价
最后更新: 2026年8月21日
1.58B USD
市值
股价为何变动
As of Aug 21, 2026, WGS closed up 5.47% at $87.06. No new same-company headline was identified in the current news window.
公司概览
业务概览
GeneDx is a genomics diagnostics company focused on rare-disease testing, exome sequencing, and clinical genetics. Its business helps clinicians diagnose difficult genetic conditions more efficiently.
所在地与行业分类
Headquartered in the United States and listed on NASDAQ, GeneDx sits in molecular diagnostics and genomics.
商业模式特征
The company depends on test adoption, reimbursement, and the expansion of genomic testing across clinical settings.
生物医药行业定位
GeneDx is a diagnostics platform name whose stock is driven by adoption, reimbursement, and workflow scale.
未来催化剂
- GeneDx’s catalysts are exome and genome testing volumes, reimbursement, and whether the rare-disease diagnostics franchise keeps expanding. The next update matters because the company’s value is still tied to workflow adoption and test mix.
近期新闻
- 01
- 02
- 03
- 04
- 05
相似股票
商业成熟度、治疗领域或催化剂模式相近的同行公司。